Decreased activity of type I 5’-monodeiodinase could lead to which physiologic effects:-

Okay, let's tackle this question about type I 5’-monodeiodinase. The question is asking what happens if the activity of this enzyme decreases. First, I need to remember what this enzyme does. I recall that deiodinases are involved in thyroid hormone metabolism. There are three types: type I, II, and III. Type I is mainly in the liver and kidneys, right? It converts T4 to T3, which is the active form of thyroid hormone. So if type I's activity is decreased, there would be less T3 being produced from T4.

The core concept here is the role of type I 5’-monodeiodinase in thyroid hormone activation. The enzyme is crucial for converting thyroxine (T4) to triiodothyronine (T3), the active form. So, decreased activity would lead to lower circulating T3 levels.

Now, the effects of reduced T3. Since T3 is the active hormone, lower levels would lead to symptoms of hypothyroidism, like fatigue, weight gain, cold intolerance. But wait, the options might be more specific. Let me think about the answer choices. The correct answer would be something related to decreased T3 or increased T4. Alternatively, maybe increased rT3? Because type III deiodinase produces reverse T3, but type I doesn't do that. Wait, type III is in the placenta and degrades T3 to reverse T3. So if type I is decreased, maybe there's less conversion to T3, leading to higher T4 but lower T3. So the physiologic effect would be decreased T3 levels.

Looking at the options, if one of them is "Decreased T3 levels," that's correct. Now, for the wrong options: if an option says "Increased T3," that's wrong because the enzyme is supposed to make T3. If another option is "Increased T4," maybe that's possible if the conversion is blocked, but T4 is the substrate, so maybe it would accumulate. However, T4 is normally converted to T3, so if the enzyme is inactive, T4 might not be converted, leading to higher T4. But I'm not sure if that's a primary effect. Also, if there's an option about increased rT3, that's more related to type III. So the main issue is reduced T3 production.

Clinical pearl: Type I deiodinase is key for peripheral conversion of T4 to T3. Inhibiting it would lower T3, mimicking hypothyroidism. A high-yield fact is that type I deiodinases are inhibited by certain drugs like amiodarone or in conditions like euthyroid sick syndrome, leading to low T3 levels.

**Core Concept**
Type I 5’-monodeiodinase catalyzes the conversion of thyroxine (T4) to triiodothyronine (T3), the biologically active thyroid hormone. Decreased activity reduces T3 production, disrupting thyroid hormone signaling in peripheral tissues. This enzyme is critical for maintaining euthyroid status, as T3 regulates metabolism, growth, and development.

**Why the Correct Answer is Right**
Reduced type I 5’-monodeiodinase activity impairs T4-to-T3 conversion, leading to **

✓ Correct Answer: B. Increased plasma reverse T3